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matory response of the immature intestinal immune sys-
tem, resulting in rapidly evolving intestinal gangrene, 
perforation, sepsis, shock and death  [1, 2, 4] .
 Probiotics have been shown to be able to modify both 
the intestinal microbiota as well as the intestinal immune 
response. On this background, several clinical trials have 
been carried out in order to investigate the potential role 
of probiotics in the prevention of necrotizing enterocoli-
tis  [5–13] . Most of these studies, among them many ran-
domized controlled trials, suggest a significant benefit of 
probiotics in the prevention of necrotizing enterocolitis, 
confirming previous observations in experimental ani-
mal models  [14, 15] . Possible mechanisms of probiotics in 
the prevention of necrotizing enterocolitis are beneficial 
modification of the intestinal microbiota, strengthening 
of the intestinal mucosal barrier and attenuating the in-
testinal immune response to bacteria and bacterial prod-
ucts. 
 The results of the randomized controlled trials have 
been analyzed in several comments and reviews  [16–19] . 
There is a general agreement that probiotic supplementa-
tion has a great potential to significantly reduce the risk 
of necrotizing enterocolitis and the overall mortality in 
premature infants with very low birth weight. However, 
there is obviously great variability of the clinical trials 
reported, with respect to inclusion criteria of the patients, 
 Necrotizing enterocolitis is one of the most serious 
gastrointestinal emergencies in the neonatal intensive-
care unit  [1] . It predominantly affects preterm infants. 
The onset of disease is usually between the 3rd and the 
10th day of life. Necrotizing enterocolitis presents with a 
wide spectrum of clinical symptoms, ranging from non-
specific gastrointestinal disturbance to a fulminant 
course of intestinal gangrene and perforation. Typical 
early signs are abdominal distension, delayed gastric 
emptying, diarrhea, abdominal tenderness and gastroin-
testinal bleeding. Characteristically, extensive hemor-
rhagic inflammatory necrosis of the terminal ileum and 
ascending colon can be found. In severe cases the entire 
bowel may be involved. Intramural hemorrhage, gan-
grene, peritonitis and edema may progress to intestinal 
necrosis with extensive infiltration of neutrophil leuko-
cytes. 
 Risk factors include prematurity, hypoxia, formula 
feeding, bacterial infection and intestinal ischemia  [2, 3] . 
Mortality is high (15–30%) and related to the presence of 
bacteremia, disseminated intravascular coagulation, as-
cites and very low birth weight. Etiology and pathogen-
esis of necrotizing enterocolitis remain unknown. How-
ever, formula feeding, intestinal mucosal barrier dys-
function and dysbalance of bacterial colonization may be 
contributing factors, leading to an inappropriate inflam-
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type and dose of probiotics used, duration of treatment 
and feeding regimens.
 A further concern is safety. Although sepsis caused by 
probiotics was not observed in any of the randomized 
controlled trials on the prevention of necrotizing entero-
colitis, there are rare case reports of systemic infections 
caused by probiotic bacteria in children with underlying 
diseases  [20–23] . The long-term safety of probiotic bacte-
ria in terms of permanent alteration in the intestinal bac-
terial colonization should also be studied. 
 In conclusion, probiotics appear to be safe and effec-
tive in preventing necrotizing enterocolitis in very low 
birth weight infants. There is increasing evidence that 
supplementation with probiotics may reduce both the 
risk of necrotizing enterocolitis as well as mortality in 
preterm infants. However, there is great heterogeneity 
among the published clinical trials and therefore insuf-
ficient information to make sound recommendations for 
the type of organism, dose and timing that should be used 
for probiotic supplementation in very low birth weight 
infants. Therefore, further large well-designed multi-
center trials are urgently needed before the use of probi-
otics in preterm infants may become routine in all neo-
natal intensive-care units.
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